Background Seizures and their consequences contribute to the burden of epilepsy because
they can cause health loss (premature mortality and residual disability). Data on the burden …

Background and objectives One year after the onset of the coronavirus disease 2019 (COVID-19)
pandemic, we aimed to summarize the frequency of neurologic manifestations …

Introduction We conducted a systematic review and meta‐analysis of the cognitive effects of
coronavirus disease 2019 (COVID‐19) in adults with no prior history of cognitive impairment…

Background Mental health is a public health issue for European young people, with great
heterogeneity in resource allocation. Representative population-based studies are needed. …

Background Understanding how prevalence, incidence, and mortality of motor neuron
diseases change over time and by location is crucial for understanding the causes of these …

Acute and post-acute neurological symptoms, signs and diagnoses have been documented
in an increasing number of patients infected by the Severe Acute Respiratory Syndrome …

Sub-Saharan Africa has become an emerging arena for digital health innovations directed
at strengthening health care, in terms of both patient management and disease surveillance …

Neurocysticercosis has been recognized as a major cause of secondary epilepsy worldwide.
So far, most of the knowledge about the disease comes from Latin America and the Indian …

Taenia solium is a zoonotic parasite prevalent in many low income countries throughout Latin
America, Asia and sub-Saharan Africa, including Tanzania. The parasite is recognized as …

Background Neurite outgrowth inhibitor A (Nogo-A) is thought to have a role in the
pathophysiology of amyotrophic lateral sclerosis (ALS). A monoclonal antibody against Nogo-A …